Welcome to our dedicated page for Ameresco SEC filings (Ticker: AMRC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ameresco, Inc. filings document the operations, financing, governance, and public-company disclosures of an energy infrastructure solutions provider. Form 8-K reports cover quarterly and annual results, supplemental financial information, project backlog commentary, energy asset activity, and material agreements related to financing arrangements and the company’s biogas business.
Ameresco’s SEC records also describe its senior secured loan agreement, revolving credit facility, term loan obligations, subsidiary guarantees, and collateral arrangements. Proxy filings cover board elections, auditor ratification, executive compensation, stock incentive plan matters, and voting by holders of Class A and Class B common stock. The filings frame risks and disclosures around energy infrastructure projects, distributed energy resources, renewable fuels, customer contracts, capital structure, and governance controls.
Ameresco, Inc. director Nickolas Stavropoulos reported exercising stock options and selling shares of Class A Common Stock over two days in February 2026. On February 12 and 13, he exercised options with a $16.33 exercise price and sold the resulting shares in open-market transactions around $34 per share.
The filing shows these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on September 8, 2025. Following the reported transactions, he held 14,111 shares of Class A Common Stock and 23,455 stock options, all as direct holdings.
An insider of AMRC filed a notice of proposed sale of 17,700 shares of common stock, to be sold through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $589,233. The company had 34,797,456 shares outstanding of this class at the time referenced. The shares come from a same-day cash exercise of stock options on 02/13/2026, matching the approximate sale date. The filer also reported recent 10b5-1 plan sales of 200 shares for $6,800 on 02/12/2026 and 100 shares for $3,400 on 01/28/2026. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.
Ameresco shareholder filed a Rule 144 notice covering the planned sale of 200 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $6,738.00 and an approximate sale date of 02/12/2026.
The shares come from an exercise of stock options on 02/12/2026, paid in cash. Over the prior three months, the same account sold 100 common shares on 01/28/2026 for gross proceeds of $3,400.00 under transactions labeled as 10b5‑1 sales.
Grantham, Mayo, Van Otterloo & Co. LLC has filed an amended Schedule 13G reporting beneficial ownership of 2,323,792 shares of Ameresco Inc common stock, representing 6.67% of the class as of 12/31/2025.
The firm reports sole power to vote and dispose of all reported shares, with no shared voting or dispositive power. It states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Ameresco.
Wellington Management Group LLP and related investment entities filed an amended Schedule 13G to report their passive ownership in Ameresco, Inc. common stock. The Wellington group reports beneficial ownership of 3,901,333 shares, with voting and dispositive power shared among affiliated advisory entities on behalf of their clients.
The filing states that the securities are held in the ordinary course of business and are not held for the purpose of changing or influencing control of Ameresco. The shares are owned of record by clients of various Wellington investment advisers, and no single client is reported to hold more than five percent of the class.
Ameresco, Inc. director Nickolas Stavropoulos reported a small, planned stock transaction involving company shares and options. On January 28, 2026, he exercised a stock option for 100 shares of Class A Common Stock at $16.33 per share and then sold 100 shares at $34 per share under a pre-arranged Rule 10b5-1 trading plan adopted on September 8, 2025.
After these transactions, he directly owned 14,111 shares of Ameresco Class A Common Stock and held 23,900 stock options. The option originally vested 20% on April 24, 2020, with the remaining 80% vesting in four equal annual installments on subsequent anniversaries.
A shareholder has filed a notice of intent to sell 100 shares of common stock under Rule 144. The planned sale, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE, has an aggregate market value of $3,302. These shares were acquired on the same date through a cash exercise of stock options. The filing notes that there are 34,797,456 shares outstanding, which serves as a baseline figure rather than the amount being sold.
Ameresco (AMRC): Ownership update. Wellington Management Group LLP and affiliated entities filed Amendment No. 2 to Schedule 13G reporting beneficial ownership of 4,735,585 shares of Ameresco common stock, representing 13.65% of the class as of 09/30/2025.
The reporting persons disclose shared voting power over 3,698,898 shares and shared dispositive power over 4,735,585 shares, with no sole voting or dispositive power. The filing notes the shares are held across advisory clients within Wellington’s structure.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Ameresco.
Grantham, Mayo, Van Otterloo & Co. LLC (GMO) filed Amendment No. 3 to a Schedule 13G reporting its beneficial ownership of Ameresco Inc. (AMRC) common stock. GMO reported beneficial ownership of 3,203,393 shares, representing 9.23% of the class, as of the event date 09/30/2025.
The filing states GMO has sole voting power and sole dispositive power over 3,203,393 shares, with no shared voting or dispositive power. GMO is identified as an investment adviser (IA). The certification affirms the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Ameresco.
Ameresco (AMRC) reported Q3 2025 results with revenues of $525,987 (in thousands), up from $500,873 (in thousands) a year ago. Operating income rose to $42,350 (in thousands) and net income attributable to common shareholders was $18,532 (in thousands), or diluted EPS of $0.35. Gross profit reached $84,329 (in thousands).
Year-to-date, cash flows from operating activities were $(37,465) (in thousands), reflecting working capital movements, while investing used $(258,282) (in thousands) mainly for energy assets, and financing provided $310,972 (in thousands). Cash, cash equivalents, and restricted cash ended at $215,596 (in thousands). Total debt and financing lease liabilities were $1,931,010 (in thousands), with $1,716,689 (in thousands) long term.
Backlog was $3,949,124 (in thousands), with ~34% expected as revenue over the next twelve months. Europe contributed strong project revenue growth, while energy asset revenue totaled $62,537 (in thousands) for the quarter. The company noted $26,683 (in thousands) of deposits with a supplier that filed Chapter 11. It is also discussing liquidated damages under an SCE agreement, with a disclosed maximum of $89 million, and obtained waivers for certain facility defaults.